SALESFORCE COM INC 4

4 · SALESFORCE COM INC · Filed Jun 5, 2017

Form 4

Period: 2017-06-05

EVP and Chief Legal Officer

Transactions

Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-06-05−88,304→ 147,175 total
Exercise: $80.99From: 2016-11-22Exp: 2022-11-22→ Common Stock (88,304 underlying)
Exercise/Conversion
Common Stock
2017-06-05$52.30/sh+82,332$4,305,964→ 82,843 total
Exercise/Conversion
Common Stock
2017-06-05$80.99/sh+88,304$7,151,741→ 171,147 total
Sale
Common Stock
2017-06-05$91.37/sh−379,189$34,645,513→ 511 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-06-05−82,332→ 31,648 total
Exercise: $52.30From: 2014-11-26Exp: 2020-11-26→ Common Stock (82,332 underlying)
Exercise/Conversion
Common Stock
2017-06-05$59.34/sh+208,553$12,375,535→ 379,700 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-06-05−208,553→ 125,132 total
Exercise: $59.34From: 2015-11-25Exp: 2021-11-25→ Common Stock (208,553 underlying)

Footnotes (4)

[F1]Weighted average price. These shares were sold in multiple transactions at prices ranging from $91.1200 to $91.7300 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
[F2]These restricted stock units vested as to 25% of the original grant on November 26, 2014 and vest as to 1/16 of the original grant quarterly thereafter.
[F3]Option is exercisable and vests over four years at the rate of 25% on November 22, 2016, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
[F4]Option is exercisable and vests over four years at the rate of 25% on November 25, 2015, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Documents

1 file